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Rejection of hemopoietic transplants  in mice has several  peculiar  immunogenetic 
features that set it apart from the rejection of solid-tissue ailografts (1, 2). The effector 
system responsible  for rejection  of marrow transplants  is composed of cells  that  are 
independent  of the  thymus  for  functional  differentiation  and  that  are  resistant  to 
lethal  doses  of who[e-body  irradiation.  The  antigens  relevant  in  marrow  allograft 
reactions  are  called  hybrid  or hemopoietic histocompatibility  (Hh) ~ antigens.  These 
antigens are not inherited codominantly and are therefore not expressed in heterozy- 
gous mice.  This pattern  of inheritance  is responsible  for the phenomenon  of hybrid 
resistance, i.e., the rejection of parental bone-marrow cell grafts by irradiated F1 mice. 
One of the Hh antigens, Hh-1, is coded for by genes linked to the D-end of the major 
histocompatibility complex H-2 (3).  Hh incompatibility is necessary, but not sufficient, 
to induce rejection of hemopoietic grafts. The ability of various inbred mouse strains 
to reject  Hh-incompatible  marrow transplants  is regulated  by two or more immune 
response  (Ir)-iike genes not linked to H-2 (4). 
The anti-Hh effector system is still  not clearly defined.  Because treatment  of mice 
with  the  long-lived  bone-seeking  isotope,  89Sr,  leads  to  the  selective  abrogation  of 
marrow allograft  reactivity, it  has been suggested that the effector cells are marrow- 
dependent  (M)  cells  (5).  Two assay systems mimic some of the  peculiar  features  of 
marrow graft rejection in vitro.  Shearer and Cudkowicz (6)  have developed a  system 
in  which  lymphocytes  from  Fl  hybrid  mice  specifically  cytotoxic  for  parental  Hh 
antigens  can  be  generated.  However,  in  contrast  to  in  vivo  hybrid  resistance,  the 
effector cells  in  this  model  are  T  lymphocytes  (7).  The  other  in  vitro  system  that 
shares many features with the in vivo anti-Hh effector cells is the natural  killer  (NK) 
-cell  system.  NK  cells,  present  in  normal  (unimmunized)  mice,  can  lyse  many 
lymphoma cell lines in vitro (8, 9). A  detailed comparison of NK-cell activity against 
YAC-1 lymphoma with marrow allograft reactivity (10) indicated a strong correlation 
between  the  two systems.  Most  impressive  is  the  abrogation  of NK activity against 
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YAC-1 cells by treatment of mice with SgSr, indicating that anti-YAC-1 NK cells are 
M  cells (10,  11). However, unlike marrow allograft reactivity, the lysis of YAC-1 cells 
in the NK assay did not seem to reflect recognition of Hh antigens (10). Recently, a 
weak  NK  reactivity against  EL-4  (H-2 b)  lymphoma cells has  been described  (12). 
Spleen cells from H-2D ~ heterozygous Fa mice lyse EL-4 cells much more efficiently 
than cells from parental (H-2 b)  mice. This similarity with in vivo hybrid resistance 
against H-2 b bone-marrow cells suggests that Hh-1 b antigens are relevant in the lysis 
of EL-4 cells in the  NK assay.  Therefore  it  appeared  to  us that  the anti-EL-4 NK 
system may be an excellent candidate for study of anti-Hh reactions in vitro. 
We report here a  detailed characterization of anti-EL-4 NK cells and comparisons 
between anti-YAC-1 and anti-EL-4 NK cells. Anti-YAC-1 NK cells are M  cells but 
anti-EL-4 NK cells are independent of the marrow microenvironment for functional 
maturation. Despite the differences in the genetic pattern of lyric interactions and in 
the effector cells themselves, the data suggest that both EL-4 and YAC-1 cells express 
Hh-1 b antigens. Hh  antigens may constitute NK recognition structures. In the next 
paper of this series, we have analyzed the relative roles of the M  cells and marrow- 
independent NK cells in mediating tumor resistance in vivo.  2 
Materials and Methods 
Mice.  CBA,  C57BL/6  (Be), DBA/2J,  B10.D2n/Sn,  B10.A,  (C57BL/6  ×  DBA/2)FI 
(B6D2Fx), and A/J mice were  purchased from The Jackson Laboratory, Bar Harbor, Maine. 
B10.A  (5R)  mice were  originally obtained from Dr. G. Cudkowicz, State University of New 
York,  Buffalo,  N.  Y.  NZB  mice were  obtained from  Ms. Jean  Eastcott,  Boston University 
School  of Medicine, Boston,  Mass.  BALB/cBy  +/+  and nu/nu  mice were  obtained from 
Sprague-Dawley Laboratories, Madison, Wis.,  and bred in our animal facility. Mice of both 
sexes were used and, where not indicated, were 6-8 wk old. 
Tumor Cells.  EL-4  (H-2 b)  lymphoma cells  obtained originally from  Dr. John  Mannick, 
Department of Surgery, Boston University School of Medicine, are maintained by serial passage 
in vivo by injecting 1-5  ×  106 cells i.p. in Be mice. The in vitro EL-4 cell line is derived from 
the in vivo cell line by culturing in RPMI-1640 (Grand Island Biological Co., Grand Island, N. 
Y.), with 10% fetal calf serum, penicillin  and streptomycin, L-glutamine, sodium pyruvate, and 
nonessential amino acids  (complete  RPMI-1640  medium). Tissue-culture-maintained EL-4 
cells become sensitive to NK activity within 4-6 wk. Before this time, the cells have a very high 
spontaneous release. Cells at this period in their passage history are frozen and stored in liquid 
nitrogen. This is necessitated because after -~24 wk in vitro, the genetic specificities  reported in 
Table I  tend to  get  lost.  YAC-1  (H-2")  lymphoma cells  were obtained as  a  tissue-culture- 
adapted  line from  Dr.  G.  Cudkowicz  and  have  been maintained in complete  RPMI-1640 
medium plus  I0%  fetal  calf serum. Tissue-cultured RLd~I (H-2d), a  radiation-induced lym- 
phoma of BALB/c  mice was  obtained from  Dr.  Howard  Holden of the  National Cancer 
Institute, Bethesda, Md. L1210 (H-2 a) was obtained from Dr. Hugues J.-P. Ryser of the Boston 
University School of Medicine. 
Preparation of Lymphoid Cell Suspensions.  This has been described previously (13). 
NK-Cell Assay.  2 ×  104 tumor cells in 0.1 ml of RPMI-1640 medium were labeled with SICr 
(New  England Nuclear,  Boston,  Mass.)  and  placed  in wells  of Microtest  II  plates  (Falcon 
Labware, Div. of Becton, Dickinson & Co.,  Oxnard, Calif.) with varying numbers of freshly 
harvested lymphoid cells in 0.1  ml of complete RPMI-1640 medium. Generally, each spleen- 
cell suspension was plated at four different effector to target-cell (E:T) ratios ranging from 100: 
1 to  12.5:1. Cells at each ratio were plated in triplicate. In the case of EL-4 cells, the effectors 
and targets were  incubated for  18 h before the supernatant fluids were collected by Titertek 
supernate collection system (Flow  Laboratories, Inc. Rockville, Md.). When YAC-I or RLdl 
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were used as targets, the incubation period was four h. The EL-4 cells are not lysed in the NK 
assay at  4  h. The ~XCr radioactivity in the supernatant fluids was counted  in a  well-type ~,- 
scintillation counter. The mean percentage of specific cytotoxicity was calculated as follows: 
•  •  •  51  •  51  mean percentage of specific cytotoxlclty  =  (  Cr cpm, experimental -  Cr cpm, spontaneous 
[medium])/(StCr  cpm,  maximum  [H20]  -  SlCr  cpm,  spontaneous)  ×  100.  The  variation 
between the replicates was <10%. Cold competition experiments were performed by fixing the 
E:T ratio at 50:1 (which is in the linear part of the curve) and the addition of varying numbers 
of cold (i.e., unlabeled) targets, generally at ratios of 10:1,20:1, and 40:1 ; cold:hot (i.e., labeled). 
SlCr-release determinations with only labeled and cold targets were performed but they were 
never significantly different from spontaneous release values. The percentage of specific lysis of 
EL-4 cells by B6DzF1 spleen cells varied from 9 to 28%  in different experiments (E:T ratios of 
50:1). Such variation in NK activity has been observed by others (1, 2). The specificity of the 
reaction at  all levels of cytotoxicity was monitored by including B6D2FI thymus cells and B6 
spleen cells as effector cells in most assays. The cytotoxicity produced by these populations was 
always significantly lower (P <0.01) than that produced by B6DzF1 spleen cells• 
Mouse Pretreatments.  6- to 8-wk-old mice were injected with two doses of 100 ~Ci 89Sr (Oak 
Ridge National Laboratory, Oak Ridge, Tenn.) i.p. and utilized 3-6 wk after the last injection. 
The mortality among B6D2F1 mice by this procedure is ~10%. Silica particles (5-/1m average 
size, gift from Dr.  K. Robock, Steinkohlenberg Vauverein, Essen-Kray, West Germany) were 
suspended in medium, sonicated, and then injected i.v. (2.5  mg/mouse) or used in vitro (100 
/tg/well). Corynebacterium  parvum was a gift of Dr. J. Hunter, Wellcome Laboratories, Raleigh, N. 
C.  Mice were  injected 2.1  mg (in 0.3 ml)  i.p. Polyinosinic:polycytidylic acid  (pI:pC)  (Sigma 
Chemical Co., St. Louis, Mo.) was injected i.p. (0.12 mg/mouse). Cyclophosphamide (CY) was 
a  gift from Mead Johnson & Co.,  Evansville, Ind.; mice were injected with 300 mg/kg body 
weight. Hydrocortisone.acetate (Merck, Sharp & Dohme, West Point, Pa.) was injected i.p. (2.5 
mg). Mice and cells were irradiated in a small-animal irradiator (Gammacell 40, Atomic Energy 
of Canada Ltd., Commercial Products, Ottawa, Ontario, Canada, dual I:~7Cs  sources, 136 rad/ 
min). 
Cell  Pretreatments.  Filtration  over  Sephadex  G-10  (Pharmacia  Fine  Chemicals,  Div.  of 
Pharmacia, Inc., Piscataway, N. J.)  columns was done by the method of Ly and Mishell (14). 
Yields of nonadherent cells varied between 40 and 50%.  Treatment with anti-Ig and comple- 
ment has been described  (15).  Treatment with anti-Thy-l.2 and complement was performed 
by the protocol described earlier. The anti-Thy-1.2 used is a monoclonal antibody derived from 
a  hybridoma (New England Nuclear, Boston, Mass.). This ~reparation, which is presumably 
free of any contaminating anti-Ly activity, has a titer of 1:10 . In preliminary characterization 
studies,  a  1:3,000  dilution of this  preparation  lysed  100%  B6D2FI  thymus  cells,  suppressed 
splenic  concanavalin A  (Con  A)  response  by  90%,  did  not  affect  B-cell  mitogenesis,  and 
suppressed  cytolytic T-cell activity completely.  B6D2F1 spleen cells were  treated  with a  very 
high concentration of this preparation (1:500) before being tested in the NK assay. 
Formation of Tumor-Cell and  Other Monolayers, and  Cell Adsorptions.  Monolayers of tumor or 
other  cells  were  prepared  by  some  modification of previously described  methods  (16,  17). 
Essentially, poly-L-lysine (PLL)  (50 #g/ml) was coated on plastic 60-mm Petri dishes (Falcon 
Labware, Div. of Becton, Dickinson & Co.) at room temperature for 1 h. After washing off the 
PLL with phosphate-buffered saline (PBS, pH  7.4), 2 ml of tumor-cell suspension (40  ×  106/ 
ml) were plated on the dish and allowed to stay at room temperature for 45 min. Nonattached 
tumor cells were then poured off and the Petri dishes were rinsed with PBS. 40  ×  106 spleen 
cells in complete RPMI-1640 medium (20 ×  106/ml) were poured on the tumor-coated dishes, 
and incubated at 37°C for 45 min. At the end, the nonadherent spleen cells were gently poured 
off and the dishes were washed once with 2  ml complete RPMI-1640 medium. The yield of 
nonadherent cells by this procedure was 30-40%•  The contamination of nonadherent spleen 
cells by the tumor cells used to make monolayers was carefully monitored (on the basis of cell 
size)  and was never >7%.  Monolayers with sheep erythrocytes  (SE)  and  7S antibody-coated 
sheep erythrocytes (SEA) were prepared exactly as described (18). 
Generation of Anti-Parent Cytotoxic T Lymphocytes.  A modification of the method described by 
Shearer and Cudkowicz was used (6). 25 ×  106 BsD2F1 spleen cells were cultured with irradiated 
(1,000 rad) 25  ×  106 B6 spleen cells in complete RPMI-1640 medium. Cultures were performed 
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incubated vertically for 5 d  in a  humidified 5% CO2 incubator. At the end of 5 d, the cytotoxic 
cells so generated  were incubated  with 5tCr-labeled  EL-4 cells in wells of Microtest  II plates 
and  the  cytotoxicity  was  measured  4  h  later.  The  collection  of supernatant  fluid  and  the 
calculations were performed as in the NK assay. The baseline controls were either tumor cells 
without any spleen cells or with B6D2Ft  spleen cells cultured with syngeneic irradiated  spleen 
cells. The latter did not cause any significant release of 5tCr above the medium control. 
Results 
Strain Distribution of Good Responders to B6 (H-2 b)  Marrow Grafts Correlates with Ability 
of Spleen Cells to Lyse EL-4 but Not YAC-1 Target Cells.  B6D2Fx, BI0.D2,  NZB,  B10.A, 
and  B10.A(5R)  mice are able  to  reject  B6 or B10 marrow  cells well and  their spleen 
cells lysed EL-4 cells well in vitro (Table I). The opposite was also true, i.e., CBA, B6, 
DBA/2,  and  A-strain  mice are poor responders  to B8 or B 10 marrow  grafts and  their 
spleen cells did not lyse EL-4 cells effectively. CBA and B6 spleen cells lyse YAC-1 but 
not  EL-4 cells well, whereas A-strain spleen ceils lyse both targets  poorly. These data 
extend  the  earlier  findings  with  the  EL-4  NK  assay  in  that  /r-like  gene  functions 
against  Hh-1 b antigens  (4)  are detected  in addition  to hybrid  resistance  (12). 
Tissue Distributions of NK Activity against EL-4 Lymphoma.  NK  activity of lymphoid 
tissues  from  B6  and  B6D2F1  mice  against  EL-4  and  YAC-1  targets  was  compared 
(Table  II).  All  B6D2F1  tissues  tested  showed  NK  activity against  EL-4  and,  in  each 
instance,  F1 cells killed the target  better than B6 parental  cells. Lysis of EL-4 cells was 
maximal by spleen, lymph node cells, and peritoneal cells. Bone marrow was relatively 
poor. Peritoneal cells and bone-marrow cells had very little NK activity against  YAC- 
1 as previously described  (9,  10). 
TABLE  [ 
Strain Distributwn of NK Activity against EL-4 and YAC-I  Tumor Cells 
Ability to reject B6  Percentage of mean cytotoxicity 
at E:T of  Mouse strain  bone-marrow  Target cells 
grafts*  100:1  50: l  25:1 
CBA  -  YAC-I:~  54.7  31.3  20.2 
B6  -  YAC- 1  46.2  29.6  17.4 
B~D2FI  +  +  YAC-I  35.4  20.5  13.0 
DBA/2  -  YAC- 1  20.5  11.3  7.0 
CBA  -  EL-4§  0.7  1.1  -0.8 
B6  -  EL-4  -1.1  0.4  0.9 
B6D2F~  +  +  EL-4  19.5  12.1  5.9 
DBA/2  -  EL-4  0.4  1.7  -2.1 
BI0.D2  +  +  EL-4  14.5  9.3  5.0 
NZB  +11  EL-4  30.7  18.7  6.4 
BI0.A  +  +  EL-4  17.3  12.1  9.2 
A  -  EL-4  4.2  1.0  1.5 
B10.A(5R)  +  EL-4  12.5  8.4  3.2 
* Data from references  1, 2,  19. Plus (+), good rejector of B6 bone marrow, minus (-), poor 
rejector of B6 bone marrow. 
YAC-1 target cells assayed in a 4-h r'lCr-release assay. 
§ EL-4 target cells assayed in an  18-h '~tCr-release assay. 
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TABLE II 
NK Activity in Different Lymphoid Tissues against EL-4 and YAC-1 Cells 
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Experiment  Lymphoid tissue  Strain of mice 
Percentage of cytotoxicity* 
EL-4~:  YAC-I§ 
l  Lymph node  B6D2F,  8.9 
B6  -11.7 
'7, 
Bone marrow  B61)2F~  5.2  18.2 
B6  2.1  4.8 
Spleen  B~D2F~  13.3  44.6 
B6  3.4  34.0 
2  Spleen  B6D2F~  22.5  39.5 
Peritoneal cells  B6D2FI  16.5  10.3 
* 50: l E:T ratio. 
:1: See Table I. 
§ See Table I. 
Characterization  of the  Anti-EL-4  NK  Cells.  NK  activity  against  EL-4  cells  was 
present  in  spleen-cell  suspensions  of BALB/c nu/nu  mice  and  was  not  sensitive  to 
treatment with rabbit anti-mouse Ig and complement (Table III). Filtration of spleen 
cells  over Sephadex  G-10 columns  and  adhesion  to  plastic  did  not  remove  the  NK 
cells. These features suggest that the cells are similar to those described  for other NK 
cells (9,  10).  However, unlike the NK cells against YAC-1  (10)  and RLdl  targets, the 
anti-EL-4 NK cells  were  not  affected by injection  of mice with  silica or incubation 
with silica particles in vitro.  Furthermore,  anti-EL-4 NK cells could not be adsorbed 
by monolayers of SEA (18). Thus, anti-EL-4 NK cells do not bear Fc receptors.  The 
efficacy of the removal of Fc  + cells in the same experiment was ascertained by testing 
antibody-dependent  cellular  cytotoxicity  (ADCC)  against  antibody-coated  chicken 
erythrocytes.  ADCC  was  reduced  by  80%.  In  our  hands,  adsorption  over  SEA 
monolayers consistently enriches  for NK activity against  EL-4. Pretreatment  of cells 
with  a  high-titered  monoclonal  anti-Thy-l.2  preparation  and  complement  did  not 
affect the NK activity against EL-4 cells. However, the very same anti-Thy-1.2-treated 
cells showed a  25-37% reduction in NK activity against YAC-1 cells. 
NK Activity against EL-4,  YA C- 1, and RLc~ I  Targets in Spleens of ~Sr-treated Mice.  Lysis 
of EL-4 cells  was  normal  in  7  out  of 10  experiments  performed  at  different  times, 
using pooled spleen cells from two 89Sr-treated B6D2Fa mice in each experiment  (Table 
IV). In the other three experiments, lysis of EL-4 cells by spleen cells from 89Sr-treated 
mice was  reduced  by  ~70%.  On  the  other  hand,  NK  activity  against  YAC-1  and 
RLdl  was consistently reduced by 70-80% in 89Sr-treated  mice.  NK activity against 
YAC-1  is detected  routinely  in a  4-h assay and  18 h  is required  for lysis of EL-4.  It 
was therefore important  to ascertain  if normal  lysis of EL-4 target  by spleen  cells of 
89Sr-treated  mice was not  an artifact  produced by a  longer incubation  time.  To this 
end, we performed the anti-YAC-I  NK assay for 18 h, and still  failed to observe lysis 
by spleen cells from a9Sr-treated  mice. The converse, i.e., 4-h anti-EL-4 assay, cannot 
be performed because spleen cells from normal mice fail to lyse EL-4 cells as rapidly. 536  HYBRID  RESISTANCE  TO  EL-4  LYMPttOMA  CELLS 
TABLE  IlI 
NK Activity against EL-4 Cells." Characterization of Effector Cells in the Spleen 
Percentage 
Experiment  Mice  Cell pretreatment  of cytotoxic- 
ity* 
% 
1  BALB/cBy + / +  --  8.6 
BALB/cBy nu/nu  --  12.0 
2  B6DzF~  --  10.9 
Normal rabbit serum  +  complement  11.0 
Anti-lg +  complement  27.0 
3  BsD2FI  --  28.1 
Filtered over Sephadex G-10  22.4 
Nonadherent to plastic  32.5 
4  B6D2FI  --  19.6 
Silica in vivo~  21.9 
5  B6D~FI  --  24.3 
Silica in vitro (preincubation)~  27.8 
Silica in vitro (in the assay):~  '.30.5 
6  B6D2Fj  --  13.1 
SE monolayer§  22.3 
SEA monolayer  27.4 
7  B~D2Fj  --  32.7 
Complement[[  '.33.1 
Anti-Thy-l.2 +  complement[[  36.6 
* Mean percentage of cytoxicity at an E:T ratio of 50:1. 
:~ Mice were injected with 2.5 mg of silica particles i.v. 24 h before sacrifice in experiment 4; in experiment 
5, 20  ×  10  ~ spleen cells were incubated with 100/.tg of silica  for 45 min at 37°C, washed once, and then 
tested; or an equal amount of silica was allowed to stay in the cell  suspension during the  18-h assay 
period. 
§ Monolayers of SE or SEA were prepared on Petri dishes as described in Methods. Cells nonadherent to 
the monolayers alter 45-rain incubation at 37°C were used.  Cells nonadherent to SEA monolayers were 
tested for ADCC against chicken erythrocytes. ADCC was reduced from 35 (control cells) to 5%. 
[[ Cytotoxicity against YAC-1  targets in the same experiment: no treatment, 24.9%; complement alone, 
25.3%; and anti-Thy-l.2 +  cmnplement, 18.4%. 
NK Activity in Neonatal and Aging Mice.  In contrast  to  NK  cells for YAC- 1 targets, 
NK-cell  activity  against  EL-4  targets  was  demonstrable  in  B6D2F1  and  BALB/cBy 
nu/nu  mice  by  5  and  7  d  of age  respectively  (Table  V).  Moreover,  the  loss  of NK 
activity against YAC-1  cells associated with ages >12  wk  (9,  10) did not occur for NK 
cells capable  of lysing EL-4 cells. 
Effect of Filtration of Spleen Cells over Sephadex  G-IO Columns.  In 89Sr-treated mice, the 
NK  activity  against  EL-4  cells  was  reduced  in  only  30%  of the experiments  (Table 
IV).  In  two  of  those  instances,  spleen  cells  of  control  and  SgSr-treated  mice  were 
filtered  over  Sephadex  G-10  columns.  Sephadex  G-10  filtration  restored  NK-cell 
activity against EL-4 cells but not against YAC- 1 cells (Table VI). The  data suggested 
that  anti-EL-4  NK  cells  are  present  in  89Sr-treated  mice  and  that  suppressor  cells 
adherent  to Sephadex  G-10 may  be responsible for the occasional  low  NK  values. VINAY  KUMAR,  EDUARDO  LUEVANO,  AND  MICHAEL  BENNE]'~F 
TABLE  IV 
Effect of SgSr Treatment  on NK Activity of BsD2Ft Spleen  Cells 
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Pretreatment of spleen cell 
donors 
Percentage of control 
Target cells  None (per-  ~Sr* (per-  values 
centage ofcy-  centage of 
totoxicity)  cytotoxicity) 
EL-4:~ 
YAC- [ 
%  % 
16.7  16.2  97 
11.5  17.9  159 
27.5  21.3  77 
18.9  20.1  106 
14.3  13.2  92 
23.5  20.9  88 
18.2  19.5  107 
(103.7  ± 
17.1  5.3  30 
19.7  6.5  32 
26.3  6.1  23 
(28.3  ± 
45.8  3.1  7 
35.6  6.2  17 
30.4  7.8  25 
29.1  6.5  22 
31.511  5.2  16 
(17.4  ± 




* Donors of spleen cells injected with 89Sr (100 uCi) i.p. on two occasions, 4 wk 
apart. Mice used 4-7 wk after the last injection. 
:~ The percentage of specific  release of 51Cr measured at  E:T  ratios of 50:1; 
incubation period was 18 h with EL-4 cells and 4 h with YAC-I and RL¢31 
cells except where indicated. 
§ Represents the average (±  SEM) of the preceding group of the percentages 
of the control values. 
[[ In this experiment YAC-1  cells were incubated for 18 h. 
TABLE  V 
Age-dependent  Changes in NK-Cell Functions 
Age of spleen 
Experiment  cell  donors  Mouse strain 
Mean percentage of specific 
cytotoxichy 
YAC- 1  EL-4 
5 d  B6DzFI  5.7"  14.5 
16 d  BnD2F~  7.9  12.3 
30 d  B6DzFI  35.1  16.7 
18 mo  B~D2FI  9.3  18.5 
7 d  BALB/c nu/nu  --  13.2 
40 d  BALB/c nu/nu  --  12.0 
* 50:1  E:T ratio; incubation periods of 4 (YAC-I) or 18  (EL-4)  h. 538  IIYBRII)  RESISTANCE TO  EL-4 LYMPttOMA  CELLS 
Adoptive  Transfer of NK-Cell Activity.  B6D2F1  mice were irradiated and repopulated 
with inocula of 1  ×  106 marrow cells or 6  ×  106 spleen cells from syngeneic donor 
mice so as  to  provide equivalent numbers of hemopoietic colony-forming cells (20). 
Recipient spleens tested at different intervals after cell transfer were inactive for NK- 
cell function against EL-4 and YAC-1 targets on day 7 (Table VII). NK cells against 
EL-4  targets  were  generated  to  near-normal  levels  by  both  spleen  and  marrow 
precursors by day 14. Marrow cells generated NK cells for YAC-1 targets more rapidly 
than did spleen cells. Such data are consistent with the concepts of separate NK-cell 
lines or two separate stages  in differentiation of a  common cell line (the  anti-EL-4 
cells preceding the anti-YAC-1 cell). 
Effects of CY, Hydrocortisone Acetate,  C. parvum,  and pI:pC on NK-Cell Function.  These 
agents had similar effects on both types of NK cells  (Table VIII). Suppression was 
detected 3 d  after injection of CY or hydrocortisone acetate and  13 d  after injection 
ofC. parvurn. Stimulation was observed 1 d  after injection of pI:pC, 3 d after injection 
ofC. parvum,  and  13 d  after injection of CY. 
Ability of Unlabeled EL-4 and  YAC-1  Cells  to Inhibit NK-Cell Activity.  To detect  any 
cross-reacting antigens on EL-4 and YAC-1 target cells, we performed NK-cell assays 
at a  50:1  E:T ratio and added varying numbers of cold  (unlabeled) EL-4 or YAC-1 
cells  at  ratio  known  to  inhibit  cytotoxicity.  We  observed  extensive  inhibition of 
cytotoxicity  toward  '~tCr-labeled YAC-I  cells  by  cold  YAC-1  and  cold  EL-4  cells 
(Table IX). The same was true for "~lCr-labeled EL-4 cells. These data indicate that 
both types of NK cells recognize both types of lymphoma cells, despite differences in 
the nature of the two cells and the time required for lysis in the two assays. 
Adsorption of Anti-EL-4 and Anti-YAC-1NK Activity by EL-4 and YAC-I Monolayers.  It 
was  important  to  verify  the  conclusions  arrived  at  by  cold  competition  by  an 
independent approach.  We prepared monolayers of YAC-1  and EL-4 cells on PLL- 
coated Petri dishes. Spleen cells were then incubated for 45 rain at  37°C on each of 
the two monolayers. Following this, the nonadherent spleen cells from each monolayer 
TABLE VI 
Effect of Sephadex G-10 Filtration on the NK Activity of Spleen Cells of~SSr-treated 
BeD~FI Mice 
Percentage of cytotoxicity of 
Sephadex G-10  NK target cells*  Pretreatment of  filtration of 
Experiment  spleen  cell donor 
cells  EL-4  YAC- I 
'7, 
Cont  rnls  No  19.7  32.6 
Yes  25.6  41.5 
"'~Sr$  No  6.5  5.2 
Yes  30.4  7.9 
Controls  No  21.8  18.5 
Yes  32. I  22.',3 
~gSr~  No  17.6  6.5 
Yes  21.2  9.4 
* Mean percentage of specific cytotoxicity at 50: l E:T ratio. Incubation periods 18 h 
(EL-4) or 4 h (YAC-I). 
100 p.Ci i.p. twice at monthly intervals: tested 4  7 wk after second injection. VINAY  KUMAR,  EDUARDO  LUEVANO, AND  MICHAEL  BENNETT 
TABLE  VII 
NK Activity of Spleen  Cells in Lethally Irradiated  Bc,  D2Ft Mice Reconstituted  by 
Normal Spleen  Cells or Bone-Marrow  Cells 
539 
Days after 
Cell type*  cell transfer 
Percentage of cytotoxicity of NK target:~ 
EL-4  YAC- 1 
Bone marrow 
Spleen 
7  5.7 (31.8)§  7.8 (26.4) 
14  14.9 (94.9)  21.7 (67.6) 
21  19.2 (112)  35.2 (94.1) 
7  6,2 (34.6)  4.6 (15.5) 
14  19.4 (I23)  7.2 (22.4) 
21  t5,6 (91.2)  14.1 (37.7) 
30  22.7 (119)  35.2 (117) 
* 1  ×  106  bone-marrow cells  or  6  ×  106  spleen  cells  were  infused  into  lethally 
irradiated (850 rad)  B6D2F1 mice. 
Mean percentage of cytotoxicity at an E:T ratio of 50:1. 
§ Numbers in parentheses represent  the cytotoxicity of spleen cells from reconstituted 
mice expressed as the percentage of the cytotoxicity observed in normal spleen cells, 
tested in parallel. 
TABLE  VIII 
Effect of Various Imrnunoregulatory Agents on NK Activity of B6D2F~ Spleen Cells against 
YAC-I and EL-4 Cells 
Experi-  Donor pretreatment*  Days after 
ment  treatment 
Mean percentage of cyto- 
toxicity of NK target cells~ 
EL-4  YAC- 1 
% 
--  --  19.4  36.5 
CY  3  2. l  15.7 
C. pawum  3  39.4  56.4 
Hydrocortisone acetate  3  4.2  14.9 
--  --  14.5  31.5 
CY  13  25.6  55.8 
C. parvum  13  4.5  6.2 
--  --  10.0  31.5 
pl:pC  1  41.7  49.5 
* Mice were injected i.p. with 300 mg/kg of CY, 2.1 mg C. parvum, 2.5 mg of hydrocortisone 
acetate, or 0.12 mg of pI:pC. 
:~ Mean percentage ofcytotoxicity at an E:T ratio of 50:1. 
were  gently eluted  and  tested  for  NK  activity  on  EL-4  and  YAC-1  targets.  It  was 
reasoned that if YAC-1  and EL-4 cells shared some common  antigen and if the anti- 
YAC-1  and  anti-EL-4  cells  shared  receptor  structures  for  the  common  antigens, 
adsorption of cells over either of the  two monolayers would  simultaneously deplete 
NK  activity  against  both  the  targets.  Nonadherent  cells  recovered  from  YAC-1  or 
EL-4  monolayers were almost  completely depleted of NK  activity against  both  the 
targets (Table X). Adsorption of spleen cells over Petri dishes coated with PLL only, 540  HYBRID  RESISTANCE TO  EL-4  LYMPHOMA CELLS 
TABLE  IX 
Competitive Inhibition of NK Activity against EL-4 and YAC-I Cells 
Percentage of inhibit ion of cytotoxicity against :* 
Cold cell type  EL-4 (cold:hot)  YAC-I (cold:hot) 
10:1  20:1  40:1  10:1  20:1  40:1 
EL-4  22  64  89  19  57  75 
YAC- 1  34  69  91  44  75  99 
* 100% cytotoxicity against  EL-4 and YAC-1  (i.e., without cold targets)  was 
19.5 and 39.7%, respectively. 
TABLE  X 
Adsorption of NK Activity against EL-4 and YAC-l Cells by EL-4 and 
YA C- 1 Monolayers 
Experi-  Adsorption  of B6DaF~ spleen 
ment  cells on 
Percentage of specific cyto- 
toxicity for* 
EL-4  YAC- 1 
--  --  51.5 
PLL only  --  50.6 
B~D2FI thymus cells  --  44.6 
YAC-I  --  5.3 
EL-4  --  10.1 
--  28.5  34.6 
SE  29.7  38.4 
YAC-I  5.3  8.4 
EL-4  3.2  5.9 
L1210  25.9  31.7 
* Mean value for 50:1 E:T ratio. 
B6D2Ft  thymus  cells,  SE,  or  DBA/2  L1210  tumor  cells  did  not  affect  NK  activity 
against  either target, indicating a  specificity for NK  cells. A  possible source of error in 
such  experiments  can  arise  from  detachment  of tumor  cells forming  the  monolayers 
during  the elution  of nonadherent  cells. The  tumor  cells mixed with  the eluted  cells 
could  then  act  as  cold  competitors  in  the  next  step  of  the  assay.  We  carefully 
monitored  for such  contamination  (Methods)  and  found  that  detached  tumor  cells 
constituted  25%  of the  nonadherent  population.  Using  an  E:T  ratio  of 50:1,  this 
degree of contamination  would  result  in  a  cold:hot  target  ratio of ~-2:1, which  is far 
below that  required  to produce  significant cold competition  (Table  IX). 
Lysis of EL-4 and YAC-I cells by B6D2FI-Anti-B6 Effector Cells Induced In  Vitro.  B~D2F1- 
anti-Be cytotoxic T  cells were generated in a  cell-mediated lympholysis (CML) system 
(6).  Irradiated  B6 (H-2 ~)  spleen cells were the stimulators  and  the 51Cr-labeled  target 
cells included EL-4 (H-2b), YAC-1 (H-2a), and L 1210 (H-2 d) tumor cells. The effector 
cells presumably  recognized Hh-1 b determinants  present on normal H-2 b hemopoietic 
cells  (6).  Both  EL-4 and  YAC-1  target  cells were lysed by the  Ft-anti-parent  effector 
cells  (Table  XI).  The  L1210  tumor  cells,  which  are  very  poor  targets  for  NK  cells, 
were not  lysed by these Fl-anti-parent  cytotoxic T  cells. VINAY KUMAR, EDUARDO LUEVANO, AND MICHAEL BENNETT 
TABLE  XI 
Lysis of EL-4 and YAC-I Cells by Be,  D2Ft Anti-Ba Cytolytic T Cells 
Target cell 
Mean percentage ofspecific cytotoxicity at E:T 
ratios 
50:1  25:1  12.5:1 
% 
EL-4  30.5  21.2  8.9 
YAC- 1  24.7  16.5  7.1 
LI210  5.1  2.7  2.0 
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Discussion 
Genetic  resistance  to  hemopoietic  allografts  and  NK-cell  activity  against  hemo- 
poietic tumors are two unusual  phenomena that  appear to have several similarities 
(10). However, the exact relationship between the effector cells responsible for the two 
activities is not  entirely clear.  Although  several studies  of NK cells have appeared 
recently, the interrelationship  between NK cells active against  various tumor target 
cells has not been elucidated. The studies reported here addressed this problem, 
NK  activity  against  tissue  culture-adapted  EL-4  cells  has  several  features  that 
distinguish it from NK activity against YAC-1 and RLc~I cells, two target cells widely 
used to investigate NK cells. NK cells for YAC-1  (10,  1 1)  or RL~I  cells (Table IV) 
and  viral-induced  NK cells  (21)  are depleted  in  mice treated  with  Sgsr,  indicating 
that such NK cells require an intact marrow microenvironment for some critical stage 
in differentiation. Thus these cells are similar to M  cells which have been previously 
suggested to be effector cells responsible for marrow ailograft  reactivity (5),  genetic 
resistance  to  the  leukemic  and  immunosuppressive  effects  of  Friend  virus  (22), 
resistance to infection with Listeria monocytogenes (23), and genetic resistance to enceph- 
alomyelitis induced  by herpes simplex virus-1  (24).  However, because we have also 
observed an increase in thymus-dependent and thymus-independent suppressor cells 
in spleens of mice treated with 89Sr (15,  25), the possibility that poor NK-cell function 
in 89Sr-treated mice is due to suppressor cells rather than to depletion of effector M 
cells  must  be considered.  We  feel  this  is  unlikely  because  we  have been  unable  to 
detect  any suppressor  cells  for anti-YAC-1  NK activity by a  variety of techniques 
previously utilized to detect suppressor cells in S9Sr-treated mice (15,  25). 3 
It should  be pointed out  that  the effects of 89Sr administration  on the  lymphoid 
system are fairly specific. After 89Sr treatment, several thymus-dependent-cell, bursa 
equivalent-dependent-cell,  and macrophage functions and/or numbers assessed by a 
variety of assays remain normal (26).  Study of 89Sr-treated mice allows the distinction 
to be made between those immune cells that are normally marrow-derived but not M 
(e.g., T  cells, B cells, macrophages) and those which are not only marrow-derived but 
are also M  cells (e.g., anti-YAC-1 NK cells). In 89Sr-treated mice the spleen takes over 
stem-cell functions and the marrow-independent cells can differentiate normally. 
In contrast to NK cell-activity against YAC-I and similar targets discussed above, 
the NK-cell activity against EL-4 cells was not usually affected by treatment of mice 
with 89Sr. In the few instances where NK activity against EL-4 cells was low in 89Sr- 
3 Kumar, V., J. Ben-Ezra, M. Bennett, and G. Sonnenfeld. Natural killer  cells  in the mice treated with 
SYSr:  normal  target-binding  cell  numbers but  inability  to  kill  even  after  interferon  administration. J. 
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treated mice, the effect was apparently due to presence of suppressor cells rather than 
to a lack of EL-4 NK cells, because the low NK activity against EL-4 could be restored 
to normal by filtration over Sephadex G-10 columns. 2 (Also, Table VI.) Note that in 
the same experiment,  the low NK activity against  YAC-1  could not be reversed by 
filtration over Sephadex G-10 columns. To our knowledge, this is the first demonstra- 
tion of two biologically (or developmentally) distinct classes of NK cells in mice:  (a) 
M  cells, and  (b) marrow-independent  (non-M)  cells. Further support  (but not proof) 
for such a conclusion comes from the comparative study of ontogeny of NK cells and 
their  generation  in  irradiated  recipients.  M-cell  activity  as  measured  by  marrow 
allograft  reactivity  (1)  and  resistance  against  Friend  virus  leukemia  (13)  does  not 
develop until mice are 3 wk old; similarly, NK-cell activity against YAC-1 cells does 
not  develop until  mice are ~18-20  d  old  (Table V,  and  [10]).  On  the other hand, 
normal  NK-cell activity against  EL-4 cells is  present  as early as 5  d  after birth.  In 
adoptive transfer experiments, it has been seen that M-cell functions (marrow allograft 
reactivity, early resistance against Listeria monocytogenes) are more efficiently generated 
in irradiated syngeneic recipients by bone-marrow cells than by spleen cells (27,  28). 
This could  be explained  by the  higher  frequency  of M-cell  precursors  in  the  bone 
marrow,  as  compared  with  the  spleen.  Correspondingly,  the  NK  activity  against 
YAC-1  cells was much more rapidly generated in irradiated  mice repopulated with 
bone-marrow cells, as compared with  recipients of normal spleen cells, even though 
six times as many spleen cells were transplanted to correct for the relative frequencies 
of the  pluripotent  stem  cells.  In  contrast,  NK-cell  activity  against  EL-4  cells  was 
generated within 15 d after transfer of spleen or bone-marrow cells. Another distinction 
between  anti-YAC-I  and  anti-EL-4  cells  is  the  susceptibility  to  anti-Thy-l.2  and 
complement.  NK activity against  EL-4 cells is not  affected by pretreatment  of the 
cells  with  a  high-titered  monoclonal  anti-Thy-l.2  and  complement,  whereas,  in 
agreement  with  the  observation  of others,  the  NK activity  against  YAC-1  cells  is 
reduced by ---30% (29). 
It  must  be pointed  out  that  there  are  also certain  similarities  between  the  anti- 
YAC-1 and anti-EL-4 NK cells. Both the activities are stimulated 3 d  after injection 
of C. pawum and suppressed 13 d after C. parvum injection or by hydrocortisone acetate 
and CY. As discussed later in this paper, these findings are consistent with the notion 
that anti-EL-4 NK cells may be the precursors of anti-YAC-1 NK cells. 
The  nature  of the  target  structures  on  most  NK-sensitive tumor cells  is  still  not 
clear.  However, in  the case of tissue-culture-adapted  EL-4 cells,  it seems very likely 
that the critical target antigen  is the same as, or similar to, the Hh-1 b antigen. This 
antigen is expressed on primitive hemopoietic cells of the C57BL/6  (H-2 b)  mice and 
appears  to  be  the  relevant  antigen  in  the  rejection  of  B6  bone-marrow  cells  by 
irradiated  mice. The Hh-I  locus has been mapped at, or close to, the  D-end of H-2 
complex and is not expressed in the heterozygous state, resulting in the rejection of B6 
bone-marrow cells by B6DzFI hybrid mice (hybrid resistance)  (3). Our suggestion that 
Hh-I b antigen is the critical target structure in the lysis of EL-4 cells in the NK assay 
is based on the strong immunogenetic correlation between NK activity against EL-4 
cells in vitro and rejection of B6 bone-marrow grafts in vivo. This can be summarized 
as follows:  (a)  hybrid resistance is seen against B6 bone-marrow grafts in vivo and in 
the  NK-cell  activity  against  EL-4  in  vitro.  This  phenomenon  cannot  be  due  to 
dominant/r-like genes inherited from the opposite parent, because the DBA/2 parent VINAY  KUMAR,  EDUARI)O  LUEVANO,  AND  MICIIAEL BENNETT  543 
itself is both  a  poor responder  to B6 bone-marrow  allografts  in  vivo and  shows poor 
NK activity against EL-4 cells in vitro (Table I). Furthermore,  when spleen cells from 
a  number of F1 mice derived  from intra-H-2 recombinant  parents were tested  (12), it 
was found  that  heterozygosity at  the  D-end of H-2 was critical  for lysis of EL-4 cells 
in  the  NK  assay.  Heterozygosity  at  other  parts  of  the  H-2  complex  was  neither 
necessary  nor  sufficient  for hybrid  resistance  in  the  NK  assay.  The  fine  genetics  of 
hybrid  resistance  against  parent  Hh-1 b antigens  in  vivo is similar to that  seen  in the 
NK  assay,  i.e.,  only  those  F1  mice  that  are  heterozygous  at  H-2D b reject  B6  bone- 
marrow cells;  (b) among inbred strains,  reactivity against  EL-4 in  vitro and  B~ bone- 
marrow grafts  in vivo is regulated  by non-H-2 genes on the C57BL  background.  For 
example, both DBA/2  and  B10.D2  are Hh-l  incompatible with  Bb, but  B10.D2  mice 
are good rejectors of B6 bone-marrow grafts, whereas DBA/2 mice are poor responders 
(30).  The  anti-EL-4  NK  reactivity  of spleen  cells  from  DBA/2  and  B10.D2  mice 
follows the same pattern.  Other such examples can be seen in Table I. 
Because the genetic pattern of NK reactivity against the YAC-1 does not correspond 
to the anti-EL-4  NK reactivity or anti-B6  (Hh-1 b)  bone-marrow  reactivity in vivo, it 
appears unlikely that the lysis of YAC-1 cells is mediately solely by recognition of Hh- 
1 b antigens  in  vitro.  However, cold competition  experiments  and  adsorption  experi- 
ments  (Tables  IX  and  X)  compel  us  to  conclude  that  YAC-1  and  EL-4  cells  must 
share some antigen  critical  for the lysis of both the targets. To resolve whether Hh-1 b 
or  some  other  antigen  (e.g.,  putative  NK  antigens)  is  shared  by  YAC-1  and  EL-4 
cells, we tested the ability of BbD2Fa anti-B6 cytotoxic T  lymphocytes to lyse EL-4 and 
YAC-1  target  cells.  Such  anti-Hh-I b cytotoxic  T  lymphocyte  lysed  EL-4  cells  and 
YAC-1  cells with  equal  efficiency  (Table  XI).  Lysis of EL-4 cells could  be inhibited 
by cold YAC-1  cells and  vice versa.  Detailed  analysis of such cross-reactive lysis  4 has 
shown that  the lysis of YAC-1  cells under these conditions  is not due to anti-fetal calf 
serum activity or persistence of NK cells of the responder spleen cells during culture. 
The anti  Hh-I b effector T  cells do not  lyse normal A-strain cells  (Con A blasts). This 
rules out the nonspecific activation of anti-H-2" clones as the reason for cross-reactive 
lysis. Other possible explanations  of cross-reactive lysis seen in some allogeneic CML 
reactions, such as sharing of public antigens  (31), is rendered  unlikely by the fact that 
H-2-associated  public antigens  are codominantly  inherited  and  therefore no cytotox- 
icity  against  classical  H-2  antigens  is  likely  to  be  generated  in  an  F1  anti-parent 
reaction.  These  data  support  the  notion  that  YAC-1  cells  express  Hh-I b  antigens. 
Expression  of inappropriate  histocompatibility  antigens on tumor cells has also been 
suggested  by other studies  (32). 
The presence of Hh-16 antigens on the YAC-1 cells may explain the cold competition 
between  YAC-1  and  EL-4 cells.  However, two other observations also need explana- 
tion:  (a) the poor lysis of YAC-1  cells by spleen cells of a9Sr-treated  mice, which seem 
to possess normal NK activity against Hh-I b-positive EL-4 cells;  (b) the lack of genetic 
correlation  between the lysis of EL-4 and YAC- 1 cells. Two models, both of which are 
consistent  with  most  of the  observed  phenomena,  are  presented  in  Fig.  1.  Model  I 
proposes  that  YAC-1  and  EL-4  are  lysed  by  two  different  subsets  of NK  cells,  and 
that the anti-YAC-I  NK cell is an M  cell. EL-4 cells bear Hh-1 b antigens and the lysis 
4 Thomas, A., V. Kumar, and M. Bennett. I lemopoietic histocompatibi[ity antigens as possible targets 
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Model I  Model II 
Fro.  1.  Two  models to explain NK-cell activity  against  EL-4 and  YAC-!  tumor  cells. (I) 
represems the Hh-I b antigen, (A) represents the NK antigen. 
of the  EL-4 cells  involves  interaction  with  anti-Hh-1 b  receptors  present  on  the  NK 
cell.  The  lysis  of  YAC-1  cells  requires  recognition  of  Hh-1 b  antigen  as  well  as 
simultaneous  recognition  of one or more other determinants.  Because  both  types of 
NK  cells  would  have  an  anti-Hh-1 b  receptor,  cold  competition  and  adsorption  by 
monolayers would be explained.  Anti-EL-4 NK cells could bind the YAC-1 cells, but 
in  the absence of the other receptor, could not  lyse them.  Because  binding and cell 
lysis are two discrete and independent steps in the NK system such a situation is quite 
conceivable (33). It is also possible that anti-EL-4 cells can lyse the YAC-1 cells, albeit 
inefficiently. The low anti-YAC-1 cytotoxicity seen in spleen cells of 89Sr-treated mice 
could  be  a  manifestation  of the  above.  Similarly,  anti-YAC-1  NK  cells  (M  cells) 
would be expected to be able to bind EL-4 cells. However, it is difficult to test whether 
M  cells can or cannot lyse EL-4 targets, because we do not have any physical method 
at  present  of selectively  depleting  the  NK  activity  against  EL-4 cells  from  normal 
spleen-cell  suspensions.  It is possible  that  anti-EL-4 NK cells are  precursors of anti- 
YAC-1  cells.  This  differentiation  of NK cells would  require  the  marrow microenvi- 
ronment.  Model  II differs  from the  previous one only in one important  aspect:  i.e., 
the lysis of YAC-1 requires participation of two cells. One of the two cells is a  non-M 
cell and  the same as EL-4 NK cell,  and the other is an M  cell.  This model,  like the 
previous  one,  can  explain  the  effect  of 89Sr  treatment,  the  cold  competition  and 
adsorption data, as well as the presence of normal frequency of YAC- 1-binding cells 
in spleens of 89Sr-treated mice. 3 Experiments to distinguish between these two models 
are in progress. 
One of the objectives of our work has been to develop an in vitro assay that would 
reflect all aspects of in vivo marrow allograft reactivity. The NK activity against  EL- 
4 fulfills most of the immunogenetic requirements  for such an assay, but seems not to 
reflect the in vivo situation entirely because the anti-EL-4 activity is retained in 89Sr- 
treated mice. On the other hand, the anti-YAC-1 NK reactivity parallels many facets 
of marrow  graft  rejection  except  for  immunogenetic  specificity.  It  is  tempting  to 
speculate  that  both  M  cells  and  non-M  cells  are  required  for  marrow  allograft 
reactivity in vivo and that the complex effector-cell system has been dissected in vitro. 
Summary 
Natural killer (NK) cells from nonimmunized mice capable of lysing EL-4 (C57BL/ 
strain  H-2 b)  tissue  culture-adapted  lymphoma  cells  have  been  analyzed  and VINAY KUMAR, EDUARDO LUEVANO,  AND  MICHAEL BENNETT  545 
compared  with  NK  cells  which  lyse  YAC-1  (A-strain,  H-2 a)  lymphoma  cells.  A 
correlation was seen in the ability of inbred and BeD2FI mice to reject C57BL/6 (Be) 
bone-marrow grafts and the ability of their spleen cells to lyse EL-4 cells in vitro. This 
suggests that hybrid or hemopoietic histocompatibility  antigens,  (Hh-lb),  relevant  in 
the rejection of Be stem cells may also be the relevant  target  structures  for the anti- 
EL-4 NK cells. Certain  features of these NK cells are similar to the NK cells reactive 
against YAC-1 cells. Both types of NK cells are present in athymic nude mice, are not 
affected  by  treatment  with  anti-immunoglobulin  plus  complement,  and  are  not 
depleted by techniques that remove macrophages. NK activity against both targets is 
stimulated  3 d  after injection of Corynebacterium  parvum, and 24 h  after challenge with 
polyinosinic:polycytidylic acid.  Hydrocortisone acetate  and  cyclophosphamide  lead 
to reduction  of NK  activity  within  2-3  d  after  administration.  However,  the  anti- 
YAC and anti-EL-4 NK reactivities differed in several important respects. Treatment 
of  mice  with  89Sr,  the  bone-seeking  isotope,  to  deplete  marrow-dependent  cells, 
depleted  the anti-YAC-1  but  not  anti-EL-4 cell  functions.  Anti-EL-4 NK cells were 
unaffected  by silica  particles  in  vivo or in vitro;  the NK cells  reactive  to EL-4 cells 
matured functionally much earlier in life (5 d of age) and the function did not decline 
with age. Irradiated  mice reconstituted  with syngeneic marrow or spleen cells devel- 
oped functional NK cells against EL-4 targets before they developed anti-YAC-1  NK 
cells in their spleen.  Thus anti-EL-4 NK cells that  express hybrid resistance  in vitro 
appear  to  differ  from  anti-YAC-1  NK  cells  and  do  not  require  an  intact  marrow 
microenvironment  for functional differentiation. 
Despite  differences in  the NK-cell types involved in the  lysis of YAC-1  and  EL-4 
cells, these two tumor cells share certain common determinants.  This was ascertained 
both by cold competition and by utilization  of YAC-1  and EL-4 cell  monolayers as 
immunoadsorbents.  We conclude that Hh-1 o is the common antigen present  in EL-4 
and YAC-1 cells, because BeDzF1 anti-Be (anti-Hh-I b)  cytotoxic T  lymphocytes lysed 
both  the  tumor cells.  Our  data  suggests  that  Hh-1 b antigen  is  recognized  by both 
types of NK cells, but that additional  determinants  must be present  on YAC- 1 cells. 
Two models of NK cell lysis compatible with the data are presented. 
Received  for publication 12 March  1979. 
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